Board Meeting14 Jul 2026, 07:10 pm
Anthem Biosciences Board Meeting on July 21, 2026 for Q1 FY27 Results
AI Summary
Anthem Biosciences Ltd has announced that its Board of Directors will convene on July 21, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. Concurrently, the company has closed its trading window from July 1, 2026, to July 23, 2026, inclusive, to comply with SEBI (Prohibition of Insider Trading) Regulations, 2015. This closure ensures adherence to regulations regarding trading by employees and connected persons around the financial results announcement. The information is also available on the company's website.
Key Highlights
- Board meeting scheduled for July 21, 2026.
- To approve Unaudited Standalone and Consolidated Financial Results.
- Trading window closed from July 1 to July 23, 2026.
- Compliance with SEBI Insider Trading Regulations.
- Results pertain to the quarter ended June 30, 2026.
Price Impact
More from ANTHEM